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I. Dioxygen Consumption Assay
KDM4A was tested for inhibition by the small molecule JIB-04 using the O2 consumption assay. The reaction solution containing 50 mM HEPES (pH 7.5), 300 µM αKG (pH 7.5), 500 µM sodium L-ascorbate, 100 µM H37-14K9me3 , and ± JIB-04 (in DMSO) was equilibrated 2 -5 min under an atmosphere of varying O2 concentration. Following equilibration, the electrode was lowered into the reaction solution, and a four minute background O2 consumption reading was allowed. Separately, purified KDM4A (2 µM) was reconstituted with Fe II (NH4)2SO4·6H2O (2 µM) and, if a pre-incubation trial, to the holoenzyme was added JIB-04 in DMSO (0 -20 µM) for a pre-incubation time of approximately one minute. In pre-incubation trials, the volume of DMSO added to the KDM4A/Fe aliquot was 1 µL (less than 20% of the HDM/Fe aliquot volume, and 0.1% of the reaction volume). The reaction was started by the addition of KDM4A/Fe/± JIB-04 to the O2 electrode chamber. All final rates were calculated by subtracting background oxygen consumption due to ascorbate and the holoenzyme in the absence of peptide substrate. Data were plotted as percentage of inhibition versus inhibitor concentration and were fit to y = 100 / (1 + ([I]/IC50)) using Kaleidagraph (Synergy Software), where IC50 is the inhibitor concentration at 50% activity.
II. MALDI-TOF MS Assay
KDM4A was tested for inhibition by the small molecule JIB-04 using a discontinuous MALDI-TOF MS assay. Purified KDM4A (8 µM) was incubated with 8 µM Fe II (NH4)2SO4·6H2O and, if a pre-incubation trial, 0-500 µM JIB-04 in DMSO. Pre-incubation trials allowed for five minutes of pre-incubation on ice before the reaction was started by the addition of a solution containing 80 µM H3(7-14)K9me3 in 50 mM HEPES (pH 7.5), 500 μM sodium L-ascorbate, and 300 µM αKG. The reaction was allowed to proceed at 37 °C for 20 minutes. The enzymatic demethylation was stopped by addition of MeOH and TFA, the precipitated protein removed via centrifugation, and the resulting supernatant collected. An aliquot of the reaction solution was added to 10 mg/mL α-cyano-4-hydroxycinnamic acid MALDI matrix in 50% acetonitrile/0.1% TFA and spotted directly onto the MALDI plate. For analysis, an ABI DE-STR MALDI-TOF instrument was used.
Percent demethylation values were determined using relative intensities of the mono-, di-, and tri-methylated H3(7-14)K9 peaks in the following equation:
Data were plotted as percent demethylation versus inhibitor concentration and were fit to y = 100 / (1 + ([I]/IC50)) using Kaleidagraph (Synergy Software), where IC50 is the inhibitor concentration at 50% activity. 
III. Molecular Docking
(E)-JIB-04 was generated using ChemDraw 3D and was energy minimized in Autodock Vina (ver. 1.1.2). Twenty low-energy poses of (E)-JIB-04 were modeled in five JmjC-HDM complexes (with crystallographic ligands removed) using grid boxes of 36 x 38 x 32 Å and the level of exhaustiveness set to 40. 
